1 Department for Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention, World Health Organization, Geneva, Switzerland.
2 Surveillance and Population-based Prevention Unit, Department of Prevention of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland.
Palliat Med. 2018 Jan;32(1):106-113. doi: 10.1177/0269216317716060. Epub 2017 Jul 5.
Previous estimates of global palliative care development have not been based on official country data.
The World Health Organization Noncommunicable Disease Country Capacity Survey of World Health Organization member state officials monitors countries' capacities for the prevention and control of noncommunicable diseases. In 2015, for the first time, questions were included on a number of palliative care development metrics to generate baseline data for monitoring global palliative care development.
Participants were given instructions, a glossary of terms, and 3 months to complete this closed, non-randomized, online survey. Questions were developed through a consultative process with relevant technical World Health Organization departments.
SETTING/PARTICIPANTS: Health ministry officials serving as noncommunicable disease focal points from 177 out of 194 (91%) of World Health Organization Member States completed the voluntary survey.
This survey reveals that (a) a minority (37%) of countries have an operational national policy for noncommunicable diseases that includes palliative care, (b) palliative care is least likely to have funding available compared with other core noncommunicable disease services, and (c) there is a large country-income gradient for palliative care funding, oral morphine availability, and integration of palliative care services at the primary levels of the health system.
Palliative care for noncommunicable disease patients must be strengthened in a majority of countries. These data provide a baseline for trend measurement of official country-level and global palliative care development. A repeat assessment is taking place in the first half of 2017.
之前对全球姑息治疗发展的评估并非基于官方国家数据。
世界卫生组织非传染性疾病成员国能力调查是世界卫生组织成员国官员对预防和控制非传染性疾病能力的监测。2015 年，首次纳入了若干姑息治疗发展指标的问题，为监测全球姑息治疗发展提供基线数据。
参与者收到了指示、术语表，并在 3 个月内完成了这项封闭的、非随机的在线调查。问题是通过与相关技术世界卫生组织部门的协商过程制定的。
地点/参与者：来自 194 个世界卫生组织成员国中的 177 个（91%）的卫生部非传染性疾病协调员完成了自愿调查。
这项调查显示：（a）少数（37%）国家有针对非传染性疾病的运作国家政策，其中包括姑息治疗；（b）与其他核心非传染性疾病服务相比，姑息治疗最不可能有资金；（c）在国家收入梯度上，姑息治疗资金、口服吗啡供应以及在初级卫生系统中整合姑息治疗服务方面存在很大差异。
必须加强大多数国家的非传染性疾病患者姑息治疗。这些数据为官方国家一级和全球姑息治疗发展的趋势衡量提供了基线。2017 年上半年将再次进行评估。
